Trump pumps Kodak

kansasquaker

Well-known member
Kodak is moving into pharmaceutical manufacturing, but "remain 100% committed to print and will continue to invest in ground-breaking innovations, especially in digital print. Print will be an important revenue source as the new pharmaceutical business gets up to speed.” ~Kodak executive chairman Jim Continenza

Lol, sounds to me 'print is going away so we need a new source of revenue.'
 

gordo

Well-known member
Here's a link to watch Trump make the announcement:


Apparently Hydroquinone - which is used in photo developer chemicals (Kodak is/was a supplier) can easily be converted into Hydroxychloroquine (generic Plaquenil) - Trump's drug of choice against Covid 19 despite the CDC's (Fauci's) and other medical bodies' objections.

Interestingly that's on top of Trump's May announcement of a four-year, $354 million contract with a fledgling company, Phlow Corporation, to build a generic medicine and API plant in Richmond, Virginia. That deal, awarded by the Department of Health and Human Services' Biomedical Advanced Research and Development Authority, could be expanded up to 10 years to a total of $812 million.
(source: Trump to Tap New Company to Make Covid-19 Drugs in the U.S.)

I wonder what the traditional drug manufacturers think of all this?
I wonder what the SEC thinks of all this. Insider trading bonanza? Apparently Kodak Chairman Jim Continenza bought 46,737 shares of Kodak stock on June 23 at an average price of $2.22. Roughly a month later, that $103,575 investment is now worth more than $1.5 million
 
Last edited:

PricelineNegotiator

Well-known member
I wonder what the traditional drug manufacturers think of all this?
I wonder what the SEC thinks of all this. Insider trading bonanza? Apparently Kodak Chairman Jim Continenza bought 46,737 shares of Kodak stock on June 23 at an average price of $2.22. Roughly a month later, that $103,575 investment is now worth more than $1.5 million
Hah. That's not even the half of it. The average trading volume for the DAY before the announcement was up 20x average daily trading volumes. I hope they get slapped shitless. This stinks of insider trading.
 

johnny_jay

Well-known member
Hah. That's not even the half of it. The average trading volume for the DAY before the announcement was up 20x average daily trading volumes. I hope they get slapped. This stinks of insider trading.
Not sure if accurate but I saw this online.
IMG_2138.PNG
 
Last edited by a moderator:

kansasquaker

Well-known member
Would you say the tall bar is roughly 20x taller than the previous shorter bar? If so, the graph is accurate - according to the CNBC article you posted anyway: "On Monday, prior to the announcement, 1,645,719 shares traded hands in the stock, far surpassing Friday’s 74,893 trades, and Thursday’s 80,840 trades . . .over the last year the average daily trading volume has been 236,479, according to FactSet."
 

PricelineNegotiator

Well-known member
Volume of shares traded does not correlate to the value of the stock increasing or decreasing. Compare the Yahoo graph to his. They aren't even the same data points...
 

PricelineNegotiator

Well-known member
Would you say the tall bar is roughly 20x taller than the previous shorter bar? If so, the graph is accurate - according to the CNBC article you posted anyway: "On Monday, prior to the announcement, 1,645,719 shares traded hands in the stock, far surpassing Friday’s 74,893 trades, and Thursday’s 80,840 trades . . .over the last year the average daily trading volume has been 236,479, according to FactSet."
I just read an article that high volume of shares being transferred was a deal struck between Kodak and Jim Continenza, where he was awarded 1.75 million shares as a bonus. Numbers still don't add up perfectly, but that surely accounts for the bump in traffic.
 

kansasquaker

Well-known member
I just read an article that high volume of shares being transferred was a deal struck between Kodak and Jim Continenza, where he was awarded 1.75 million shares as a bonus. Numbers still don't add up perfectly, but that surely accounts for the bump in traffic.
It looks like we'll find out. SEC is going to investigate. I think the 1.75 million shares were just options. I don't think that would show up in trade volume.

 

Alith7

Well-known member
Kodak is moving into pharmaceutical manufacturing, but "remain 100% committed to print and will continue to invest in ground-breaking innovations, especially in digital print. Print will be an important revenue source as the new pharmaceutical business gets up to speed.” ~Kodak executive chairman Jim Continenza

Lol, sounds to me 'print is going away so we need a new source of revenue.'
More like "we have successfully lost any market share we had left in the print industry through poor product management and archaic technology that was never advanced, so now we need to do something..."
 

Automatically Autonomous Automation

Automatically Autonomous Automation
Although the autonomous car is not quite ready, a lights out print operation is something you can do right now if you have a comprehensive Print MIS (Management Information System). The advantages can put money on your bottom line. So what’s your next step? Link to Article

   
Top